Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.

Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, Clubb RJ, An W, Ahmed D, El-Ansari R, Storck MD, Mishra NK, Guda C, Sheinin YM, Meza JL, Raja S, Rakha EA, Band V, Band H.

Cancer Res. 2018 May 15;78(10):2524-2535. doi: 10.1158/0008-5472.CAN-16-2140. Epub 2018 Mar 6.

PMID:
29510992
2.

Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function.

Iseka FM, Goetz BT, Mushtaq I, An W, Cypher LR, Bielecki TA, Tom EC, Arya P, Bhattacharyya S, Storck MD, Semerad CL, Talmadge JE, Mosley RL, Band V, Band H.

J Immunol. 2018 Jan 15;200(2):483-499. doi: 10.4049/jimmunol.1601793. Epub 2017 Dec 6.

PMID:
29212907
3.

EHD4 is a novel regulator of urinary water homeostasis.

Rahman SS, Moffitt AEJ, Trease AJ, Foster KW, Storck MD, Band H, Boesen EI.

FASEB J. 2017 Dec;31(12):5217-5233. doi: 10.1096/fj.201601182RR. Epub 2017 Aug 4.

PMID:
28778975
4.

Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway.

Srivastava S, Mohibi S, Mirza S, Band H, Band V.

Cell Cycle. 2017 Aug 18;16(16):1515-1525. doi: 10.1080/15384101.2017.1339846. Epub 2017 Jul 31.

5.

The extracellular role of DNA damage repair protein APE1 in regulation of IL-6 expression.

Nath S, Roychoudhury S, Kling MJ, Song H, Biswas P, Shukla A, Band H, Joshi S, Bhakat KK.

Cell Signal. 2017 Nov;39:18-31. doi: 10.1016/j.cellsig.2017.07.019. Epub 2017 Jul 25.

PMID:
28751279
6.

Mammalian ECD Protein Is a Novel Negative Regulator of the PERK Arm of the Unfolded Protein Response.

Olou AA, Sarkar A, Bele A, Gurumurthy CB, Mir RA, Ammons SA, Mirza S, Saleem I, Urano F, Band H, Band V.

Mol Cell Biol. 2017 Aug 28;37(18). pii: e00030-17. doi: 10.1128/MCB.00030-17. Print 2017 Sep 15.

7.

CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.

Lv K, Jiang J, Donaghy R, Riling CR, Cheng Y, Chandra V, Rozenova K, An W, Mohapatra BC, Goetz BT, Pillai V, Han X, Todd EA, Jeschke GR, Langdon WY, Kumar S, Hexner EO, Band H, Tong W.

Genes Dev. 2017 May 15;31(10):1007-1023. doi: 10.1101/gad.297135.117. Epub 2017 Jun 13.

8.

Corrigendum: Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.

Bhattacharyya S, Rainey MA, Arya P, Mohapatra BC, Mushtaq I, Dutta S, George M, Storck MD, McComb RD, Muirhead D, Todd GL, Gould K, Datta K, Waes JG, Band V, Band H.

Sci Rep. 2017 Mar 23;7:42320. doi: 10.1038/srep42320. No abstract available.

9.

An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.

Mohapatra B, Zutshi N, An W, Goetz B, Arya P, Bielecki TA, Mustaq I, Storck MD, Meza JL, Band V, Band H.

Development. 2017 Mar 15;144(6):1072-1086. doi: 10.1242/dev.138164. Epub 2017 Jan 18.

10.

Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.

Nadeau SA, An W, Mohapatra BC, Mushtaq I, Bielecki TA, Luan H, Zutshi N, Ahmad G, Storck MD, Sanada M, Ogawa S, Band V, Band H.

J Biol Chem. 2017 Mar 3;292(9):3666-3682. doi: 10.1074/jbc.M116.772723. Epub 2017 Jan 12.

11.

Mutant PIK3CA Induces EMT in a Cell Type Specific Manner.

Bhagirath D, Zhao X, Mirza S, West WW, Band H, Band V.

PLoS One. 2016 Dec 12;11(12):e0167064. doi: 10.1371/journal.pone.0167064. eCollection 2016.

12.

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.

Griffin NI, Sharma G, Zhao X, Mirza S, Srivastava S, Dave BJ, Aleskandarany M, Rakha E, Mohibi S, Band H, Band V.

Breast Cancer Res. 2016 Nov 16;18(1):113.

13.

Corrigendum to CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface [Cell Signalling 2016 Sep.; 28(9): 1325-35].

Cypher LR, Bielecki TA, Huang L, An W, Iseka F, Tom E, Storck MD, Hoppe AD, Band V, Band H.

Cell Signal. 2016 Dec;28(12):1933. doi: 10.1016/j.cellsig.2016.07.018. Epub 2016 Aug 7. No abstract available.

14.

VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.

An W, Mohapatra BC, Zutshi N, Bielecki TA, Goez BT, Luan H, Iseka F, Mushtaq I, Storck MD, Band V, Band H.

Oncotarget. 2016 Sep 13;7(37):59006-59016. doi: 10.18632/oncotarget.10638.

15.

Acetylation of Mammalian ADA3 Is Required for Its Functional Roles in Histone Acetylation and Cell Proliferation.

Mohibi S, Srivastava S, Bele A, Mirza S, Band H, Band V.

Mol Cell Biol. 2016 Sep 12;36(19):2487-502. doi: 10.1128/MCB.00342-16. Print 2016 Oct 1.

16.

A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.

Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck MD, Meza J, Sheinin Y, Band V, Band H.

Oncotarget. 2016 Aug 9;7(32):51107-51123. doi: 10.18632/oncotarget.9812.

17.

CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.

Cypher LR, Bielecki TA, Huang L, An W, Iseka F, Tom E, Storck MD, Hoppe AD, Band V, Band H.

Cell Signal. 2016 Sep;28(9):1325-35. doi: 10.1016/j.cellsig.2016.05.013. Epub 2016 May 17.

18.

Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.

Bhattacharyya S, Rainey MA, Arya P, Dutta S, George M, Storck MD, McComb RD, Muirhead D, Todd GL, Gould K, Datta K, Gelineau-van Waes J, Band V, Band H.

Sci Rep. 2016 Feb 17;6:20727. doi: 10.1038/srep20727.

19.

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition.

Raja SM, Desale SS, Mohapatra B, Luan H, Soni K, Zhang J, Storck MA, Feng D, Bielecki TA, Band V, Cohen SM, Bronich TK, Band H.

Oncotarget. 2016 Mar 1;7(9):10522-35. doi: 10.18632/oncotarget.7231.

20.

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.

Shukla A, Rai K, Shukla V, Chaturvedi NK, Bociek RG, Pirruccello SJ, Band H, Lu R, Joshi SS.

Blood. 2016 May 12;127(19):2310-21. doi: 10.1182/blood-2015-09-669317. Epub 2016 Jan 25.

Supplemental Content

Loading ...
Support Center